Home / Infectious Disease & Vaccines
Infectious Disease & Vaccines
| 4 min read
Merck researchers developed an effective vaccine against pneumococcal diseases.
| 3 min read
In a mix of innovation and accident, researchers developed a new antibiotic that has broad efficacy across Gram-positive bacteria.
| 4 min read
Proteins from intracellular pathogens can help expel drugs delivered by macrophages.
| 9 min read
There is no vaccine against this parasitic worm infection, but rhesus macaques’ unique immune system has brought the prospect of a vaccine closer than ever.
| 4 min read
Scientists developed an unprecedented chemical tool to visualize sphingomyelin and sphingomyelinase activity during a chlamydia infection.
| 3 min read
Organ-on-a-chip technology can replicate the cervix microenvironment in bacterial vaginosis.
| 3 min read
Bacteria can invade colorectal cancer tumors, leading to worse disease outcomes. Oxygen — or lack thereof — plays a vital role in this interaction.
| 4 min read
An agreement enables GSK access to enzymatic production technology for rapid GMP production of DNA template for mRNA vaccine manufacturing.
| 3 min read
Nonhuman primates treated with the mRNA vaccine recovered faster and had less severe disease than those given available mpox vaccines.
| 7 min read
A new model predicts how well maternal vaccines protect babies from Group B Streptococcus, propelling much needed shots through late-stage clinical trials.
| 3 min read
Plectasin forms dense structures on bacterial membranes by binding to unique lipids in bacterial cell walls.
| 4 min read
Researchers uncovered the structure of the measles fusion glycoprotein and identified a neutralizing antibody capable of decreasing its virulence.
